{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T17:46:26Z","timestamp":1792259186529,"version":"4.4.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T00:00:00Z","timestamp":1711238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T00:00:00Z","timestamp":1711238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/35\/N\/NZ5\/04431"],"award-info":[{"award-number":["2019\/35\/N\/NZ5\/04431"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Endothelial dysfunction (ED) is defined as an impairment in the vasodilatory, anti-thrombotic, and anti-inflammatory properties of the cells that make up the lining of blood vessels. ED is considered a key step in the development of atherosclerotic cardiovascular disease. The association between ED and systemic inflammatory diseases is well established. However, the prevalence and clinical significance of ED in psoriatic arthritis (PsA) have been investigated to a lesser extent. This review aims to explore the link between ED and PsA, including ED in macro- and microcirculation, as well as risk factors for its occurrence in PsA and its relationship with atherosclerosis in PsA. Furthermore, the ED in PsA was compared with that of rheumatoid arthritis (RA). Regarding ED in the microcirculation, the coronary flow reserve was found to be significantly reduced in individuals with PsA. The relationship between PsA and macrovascular ED is more pronounced, along with more advanced atherosclerosis detected in patients with PsA. These results are consistent with those obtained in RA studies. On the other hand, arterial stiffness and signs of vascular remodeling were found more frequently in RA than in PsA, with the potential role of efficient anti-TNF treatment in patients with PsA and psoriasis explaining this finding. The impact of ED on cardiovascular diseases and the burden of this risk caused independently by PsA have not yet been precisely established, however, this group of patients requires special attention with regard to cardiovascular events.<\/jats:p>","DOI":"10.1007\/s00296-024-05556-x","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T09:01:18Z","timestamp":1711270878000},"page":"1587-1606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Endothelial dysfunction and risk factors for atherosclerosis in psoriatic arthritis: overview and comparison with rheumatoid arthritis"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7808-8071","authenticated-orcid":false,"given":"Konrad","family":"Kaleta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2830-8959","authenticated-orcid":false,"given":"Julia","family":"Krupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0591-4819","authenticated-orcid":false,"given":"Wiktoria","family":"Suchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8462-9358","authenticated-orcid":false,"given":"Anna","family":"Sopel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-9739","authenticated-orcid":false,"given":"Mariusz","family":"Korkosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8748-7581","authenticated-orcid":false,"given":"Jaros\u0142aw","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,24]]},"reference":[{"key":"5556_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376:957\u2013970. https:\/\/doi.org\/10.1056\/NEJMra1505557","journal-title":"N Engl J Med"},{"key":"5556_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s40265-014-0191-y","volume":"74","author":"PJ Mease","year":"2014","unstructured":"Mease PJ, Armstrong AW (2014) Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs 74:423\u2013441. https:\/\/doi.org\/10.1007\/s40265-014-0191-y","journal-title":"Drugs"},{"key":"5556_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","volume":"17","author":"LC Coates","year":"2017","unstructured":"Coates LC, Helliwell PS (2017) Psoriatic arthritis: state of the art review. Clin Med 17:65\u201370. https:\/\/doi.org\/10.7861\/clinmedicine.17-1-65","journal-title":"Clin Med"},{"key":"5556_CR4","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1365-2133.2007.08148.x","volume":"157","author":"DH Ciocon","year":"2007","unstructured":"Ciocon DH, Kimball AB (2007) Psoriasis and psoriatic arthritis: separate or one and the same? Br J Dermatol 157:850\u2013860. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08148.x","journal-title":"Br J Dermatol"},{"key":"5556_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4081\/reumatismo.2011.148","volume":"63","author":"F Atzeni","year":"2011","unstructured":"Atzeni F, Turiel M, Boccassini L et al (2011) Cardiovascular involvement in psoriatic arthritis. Reumatismo 63:148\u2013154. https:\/\/doi.org\/10.4081\/reumatismo.2011.148","journal-title":"Reumatismo"},{"key":"5556_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00004872-200501000-00004","volume":"23","author":"J Deanfield","year":"2005","unstructured":"Deanfield J, Donald A, Ferri C et al (2005) Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 23:7\u201317. https:\/\/doi.org\/10.1097\/00004872-200501000-00004","journal-title":"J Hypertens"},{"key":"5556_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3109\/07853890.2015.1031822","volume":"47","author":"MND di Minno","year":"2015","unstructured":"di Minno MND, Ambrosino P, Lupoli R et al (2015) Cardiovascular risk markers in patients with psoriatic arthritis: a meta-analysis of literature studies. Ann Med 47:346\u2013353. https:\/\/doi.org\/10.3109\/07853890.2015.1031822","journal-title":"Ann Med"},{"key":"5556_CR8","first-page":"2167","volume":"33","author":"C Han","year":"2006","unstructured":"Han C, Robinson DW, Hackett MV et al (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167\u20132172","journal-title":"J Rheumatol"},{"key":"5556_CR9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16853","author":"M Jamil","year":"2021","unstructured":"Jamil M, Aslam R, Patel A et al (2021) Prevalence and extent of subclinical atherosclerosis and associated cardiovascular risk factors in adult patients with psoriatic arthritis: a systematic review. Cureus. https:\/\/doi.org\/10.7759\/cureus.16853","journal-title":"Cureus"},{"key":"5556_CR10","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H et al (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"5556_CR11","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3899\/jrheum.100893","volume":"38","author":"F Atzeni","year":"2011","unstructured":"Atzeni F, Sarzi-Puttini P, Sitia S et al (2011) Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritis. J Rheumatol 38:1661\u20131664. https:\/\/doi.org\/10.3899\/jrheum.100893","journal-title":"J Rheumatol"},{"key":"5556_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2167-7921.1000119","volume":"03","author":"RA Mahfouz","year":"2014","unstructured":"Mahfouz RA, Mostafa T, Fahmy DS (2014) Impact of the neutrophil-to-lymphocyte ratio on coronary flow reserve and incipient myocardial dysfunction in patients with psoriatic arthritis. J Arthritis 03:1\u20135. https:\/\/doi.org\/10.4172\/2167-7921.1000119","journal-title":"J Arthritis"},{"key":"5556_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2019.08.009","volume":"289","author":"S Piaserico","year":"2019","unstructured":"Piaserico S, Osto E, Famoso G et al (2019) Long-term prognostic value of coronary flow reserve in psoriasis patients. Atherosclerosis 289:57\u201363. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.08.009","journal-title":"Atherosclerosis"},{"key":"5556_CR14","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1093\/eurheartj\/ehac544.2643","volume":"43","author":"I Ikonomidis","year":"2022","unstructured":"Ikonomidis I, Pavlidis G, Katogiannis K et al (2022) Differences in coronary flow reserve and flow-mediated dilation between plaque psoriasis and psoriatic arthritis. Eur Heart J 43:2643. https:\/\/doi.org\/10.1093\/eurheartj\/ehac544.2643","journal-title":"Eur Heart J"},{"key":"5556_CR15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/annrheumdis-2016-eular.5725","volume":"75","author":"G Murdaca","year":"2016","unstructured":"Murdaca G, Bezante G, Penza E et al (2016) Endothelial dysfunction in psoriatic arthritis: evaluation by endothelial-dependent flow-mediated dilation and coronary flow reserve. Ann Rheum Dis 75:600. https:\/\/doi.org\/10.1136\/annrheumdis-2016-eular.5725","journal-title":"Ann Rheum Dis"},{"key":"5556_CR16","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.jid.2023.02.037","volume":"143","author":"S Piaserico","year":"2023","unstructured":"Piaserico S, Papadavid E, Cecere A et al (2023) Coronary microvascular dysfunction in asymptomatic patients with severe psoriasis. J Invest Dermatol 143:1929-1936.e2. https:\/\/doi.org\/10.1016\/j.jid.2023.02.037","journal-title":"J Invest Dermatol"},{"key":"5556_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2016.05.036","volume":"251","author":"S Piaserico","year":"2016","unstructured":"Piaserico S, Osto E, Famoso G et al (2016) Treatment with tumor necrosis factor inhibitors restores coronary microvascular function in young patients with severe psoriasis. Atherosclerosis 251:25\u201330. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.05.036","journal-title":"Atherosclerosis"},{"key":"5556_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00005-017-0465-7","volume":"65","author":"L Moroni","year":"2017","unstructured":"Moroni L, Selmi C, Angelini C et al (2017) Evaluation of endothelial function by flow-mediated dilation: a comprehensive review in rheumatic disease. Arch Immunol Ther Exp (Warsz) 65:463\u2013475. https:\/\/doi.org\/10.1007\/s00005-017-0465-7","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"5556_CR19","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00296-015-3228-y","volume":"35","author":"B Yilmazer","year":"2015","unstructured":"Yilmazer B, Sahin T, Unlu B\u00d6 et al (2015) Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity. Rheumatol Int 35:1385\u20131392. https:\/\/doi.org\/10.1007\/s00296-015-3228-y","journal-title":"Rheumatol Int"},{"key":"5556_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/art.22530","volume":"57","author":"C Gonzalez-Juanatey","year":"2007","unstructured":"Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA et al (2007) Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Care Res (Hoboken) 57:287\u2013293. https:\/\/doi.org\/10.1002\/art.22530","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5556_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5543\/tkda.2018.36169","volume":"46","author":"\u015eA Bilgen","year":"2018","unstructured":"Bilgen \u015eA, Kalyoncu U, Erden A et al (2018) Assessment of subclinical atherosclerosis in psoriatic arthritis patients without clinically overt cardiovascular disease or traditional atherosclerosis risk factors. Turk Kardiyol Dern Ars 46:358\u2013365. https:\/\/doi.org\/10.5543\/tkda.2018.36169","journal-title":"Turk Kardiyol Dern Ars"},{"key":"5556_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14712\/18059694.2018.122","volume":"61","author":"L Turo\u0148ov\u00e1","year":"2018","unstructured":"Turo\u0148ov\u00e1 L, Kubejov\u00e1 K, Vor\u010d\u00e1kov\u00e1 K et al (2018) Endothelial dysfunction in children with juvenile psoriatic arthritis. Acta Medica (Hradec Kralove) 61:79\u201385. https:\/\/doi.org\/10.14712\/18059694.2018.122","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"5556_CR23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/1756-185X.12336","volume":"19","author":"A Sharma","year":"2014","unstructured":"Sharma A, Reddy MH, Sharma K et al (2014) Study of endothelial dysfunction in patients of psoriatic arthritis by flow mediated and nitroglycerine mediated dilatation of brachial artery. Int J Rheum Dis 19:300\u2013304. https:\/\/doi.org\/10.1111\/1756-185X.12336","journal-title":"Int J Rheum Dis"},{"key":"5556_CR24","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1161\/01.CIR.0000029802.88087.5E","volume":"106","author":"S Verma","year":"2002","unstructured":"Verma S, Wang CH, Li SH et al (2002) A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106:913\u2013919. https:\/\/doi.org\/10.1161\/01.CIR.0000029802.88087.5E","journal-title":"Circulation"},{"key":"5556_CR25","doi-asserted-by":"publisher","first-page":"12315","DOI":"10.3390\/ijms131012315","volume":"13","author":"T Dimitroulas","year":"2012","unstructured":"Dimitroulas T, Sandoo A, Kitas GD (2012) Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases. Int J Mol Sci 13:12315\u201312335. https:\/\/doi.org\/10.3390\/ijms131012315","journal-title":"Int J Mol Sci"},{"key":"5556_CR26","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1093\/rheumatology\/kes213","volume":"51","author":"Q Shang","year":"2012","unstructured":"Shang Q, Tam LS, Sanderson JE et al (2012) Increase in ventricular-arterial stiffness in patients with psoriatic arthritis. Rheumatology (Oxford) 51:2215\u20132223. https:\/\/doi.org\/10.1093\/rheumatology\/kes213","journal-title":"Rheumatology (Oxford)"},{"key":"5556_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40001-018-0352-7","volume":"23","author":"D Patschan","year":"2018","unstructured":"Patschan D, Sugiarto N, Henze E et al (2018) Early endothelial progenitor cells and vascular stiffness in psoriasis and psoriatic arthritis. Eur J Med Res 23:56. https:\/\/doi.org\/10.1186\/s40001-018-0352-7","journal-title":"Eur J Med Res"},{"key":"5556_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1472-8206.2010.00872.x","volume":"25","author":"K Angel","year":"2011","unstructured":"Angel K, Provan SA, Hammer HB et al (2011) Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies. Fundam Clin Pharmacol 25:511\u2013517. https:\/\/doi.org\/10.1111\/j.1472-8206.2010.00872.x","journal-title":"Fundam Clin Pharmacol"},{"key":"5556_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/art.40695","volume":"71","author":"IT Cheng","year":"2019","unstructured":"Cheng IT, Shang Q, Li EK et al (2019) Effect of achieving minimal disease activity on the progression of subclinical atherosclerosis and arterial stiffness: a prospective cohort study in psoriatic arthritis. Arthritis Rheumatol 71:271\u2013280. https:\/\/doi.org\/10.1002\/art.40695","journal-title":"Arthritis Rheumatol"},{"key":"5556_CR30","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1093\/rheumatology\/keaa025","volume":"59","author":"IT Cheng","year":"2020","unstructured":"Cheng IT, Li EK, Wong PC et al (2020) Treat to target and prevention of subclinical atherosclerosis in psoriatic arthritis\u2014which target should we choose? Rheumatology (Oxford) 59:2881\u20132892. https:\/\/doi.org\/10.1093\/rheumatology\/keaa025","journal-title":"Rheumatology (Oxford)"},{"key":"5556_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2174\/138161282004140213123852","volume":"20","author":"EA Brezinski","year":"2014","unstructured":"Brezinski EA, Follansbee MR, Armstrong EJ et al (2014) Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review. Curr Pharm Des 20:513\u2013528. https:\/\/doi.org\/10.2174\/138161282004140213123852","journal-title":"Curr Pharm Des"},{"key":"5556_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/s1885-5857(09)71520-8","volume":"62","author":"M Soy","year":"2009","unstructured":"Soy M, Yildiz M, Sevki Uyanik M et al (2009) Susceptibility to atherosclerosis in patients with psoriasis and psoriatic arthritis as determined by carotid\u2013femoral (aortic) pulse-wave velocity measurement. Rev Esp Cardiol 62:96\u201399. https:\/\/doi.org\/10.1016\/s1885-5857(09)71520-8","journal-title":"Rev Esp Cardiol"},{"key":"5556_CR33","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/annrheumdis-2022-eular.2670","volume":"81","author":"K Triantafyllias","year":"2022","unstructured":"Triantafyllias K, Liverakos S, Klonowski A et al (2022) High cardiovascular risk in patients with psoriatic arthritis: evaluation of macroangiopathy and its predictors by aortic pulse wave velocity. Ann Rheum Dis 81:869\u2013870. https:\/\/doi.org\/10.1136\/annrheumdis-2022-eular.2670","journal-title":"Ann Rheum Dis"},{"key":"5556_CR34","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10067-011-1892-1","volume":"31","author":"L Costa","year":"2012","unstructured":"Costa L, Caso F, D\u2019Elia L et al (2012) Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study. Clin Rheumatol 31:711\u2013715. https:\/\/doi.org\/10.1007\/s10067-011-1892-1","journal-title":"Clin Rheumatol"},{"key":"5556_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13075-015-0570-0","volume":"17","author":"J Shen","year":"2015","unstructured":"Shen J, Shang Q, Li EK et al (2015) Cumulative inflammatory burden is independently associated with increased arterial stiffness in patients with psoriatic arthritis: a prospective study. Arthritis Res Ther 17:75. https:\/\/doi.org\/10.1186\/s13075-015-0570-0","journal-title":"Arthritis Res Ther"},{"key":"5556_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/cvr\/20.3.208","volume":"20","author":"T Imura","year":"1986","unstructured":"Imura T, Yamamoto K, Kanamori K et al (1986) Non-invasive ultrasonic measurement of the elastic properties of the human abdominal aorta. Cardiovasc Res 20:208\u2013214. https:\/\/doi.org\/10.1093\/cvr\/20.3.208","journal-title":"Cardiovasc Res"},{"key":"5556_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/1874192401004020083","volume":"4","author":"M Yildiz","year":"2010","unstructured":"Yildiz M (2010) Arterial distensibility in chronic inflammatory rheumatic disorders. Open Cardiovasc Med J 4:83\u201388. https:\/\/doi.org\/10.2174\/1874192401004020083","journal-title":"Open Cardiovasc Med J"},{"key":"5556_CR38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/HYPERTENSIONAHA.109.143982","volume":"55","author":"K Angel","year":"2010","unstructured":"Angel K, Provan SA, Gulseth HL et al (2010) Tumor necrosis factor-\u03b1 antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension 55:333\u2013338. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.143982","journal-title":"Hypertension"},{"key":"5556_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1055\/s-2003-40058","volume":"24","author":"M Ludwig","year":"2003","unstructured":"Ludwig M, Petzinger-Kruthoff AV, Buquoy MV et al (2003) Intima-media-dicke der karotisarterien: fr\u00fcher indikator f\u00fcr arteriosklerose und therapeutischer endpunkt. Ultraschall Med 24:162\u2013174. https:\/\/doi.org\/10.1055\/s-2003-40058","journal-title":"Ultraschall Med"},{"key":"5556_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5551\/jat.31989","volume":"23","author":"T Nezu","year":"2016","unstructured":"Nezu T, Hosomi N, Aoki S et al (2016) Carotid intima-media thickness for atherosclerosis. J Atheroscler Thromb 23:18\u201331. https:\/\/doi.org\/10.5551\/jat.31989","journal-title":"J Atheroscler Thromb"},{"key":"5556_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","volume":"36","author":"O Kimhi","year":"2007","unstructured":"Kimhi O, Caspi D, Bornstein NM et al (2007) Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 36:203\u2013209. https:\/\/doi.org\/10.1016\/j.semarthrit.2006.09.001","journal-title":"Semin Arthritis Rheum"},{"key":"5556_CR42","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/art.24014","volume":"59","author":"LS Tam","year":"2008","unstructured":"Tam LS, Shang Q, Li EK et al (2008) Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Care Res (Hoboken) 59:1322\u20131331. https:\/\/doi.org\/10.1002\/art.24014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5556_CR43","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1055\/s-0036-1584918","volume":"25","author":"N Garg","year":"2016","unstructured":"Garg N, Krishan P, Syngle A (2016) Atherosclerosis in psoriatic arthritis: a multiparametric analysis using imaging technique and laboratory markers of inflammation and vascular function. Int J Angiol 25:222\u2013228. https:\/\/doi.org\/10.1055\/s-0036-1584918","journal-title":"Int J Angiol"},{"key":"5556_CR44","first-page":"877","volume":"35","author":"L Eder","year":"2008","unstructured":"Eder L, Zisman D, Barzilai M et al (2008) Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol 35:877\u2013882","journal-title":"J Rheumatol"},{"key":"5556_CR45","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003576","volume":"95","author":"N Fang","year":"2016","unstructured":"Fang N, Jiang M, Fan Y (2016) Association between psoriasis and subclinical atherosclerosis. Medicine (Baltimore) 95:e3576. https:\/\/doi.org\/10.1097\/MD.0000000000003576","journal-title":"Medicine (Baltimore)"},{"key":"5556_CR46","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1136\/annrheumdis-2020-217595","volume":"79","author":"SHM Lam","year":"2020","unstructured":"Lam SHM, Cheng IT, Li EK et al (2020) DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study. Ann Rheum Dis 79:1320\u20131326. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217595","journal-title":"Ann Rheum Dis"},{"key":"5556_CR47","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13075-016-1074-2","volume":"18","author":"M Lucke","year":"2016","unstructured":"Lucke M, Messner W, Kim ESH et al (2016) The impact of identifying carotid plaque on addressing cardiovascular risk in psoriatic arthritis. Arthritis Res Ther 18:178. https:\/\/doi.org\/10.1186\/s13075-016-1074-2","journal-title":"Arthritis Res Ther"},{"key":"5556_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001364","volume":"6","author":"IT Cheng","year":"2020","unstructured":"Cheng IT, Wong KT, Li EK et al (2020) Comparison of carotid artery ultrasound and Framingham risk score for discriminating coronary artery disease in patients with psoriatic arthritis. RMD Open 6:e001364. https:\/\/doi.org\/10.1136\/rmdopen-2020-001364","journal-title":"RMD Open"},{"key":"5556_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.932696","volume":"9","author":"IT Cheng","year":"2022","unstructured":"Cheng IT, Meng H, Li M et al (2022) Serum calprotectin level is independently associated with carotid plaque presence in patients with psoriatic arthritis. Front Med (Lausanne) 9:932696. https:\/\/doi.org\/10.3389\/fmed.2022.932696","journal-title":"Front Med (Lausanne)"},{"key":"5556_CR50","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/annrheumdis-2012-201497","volume":"72","author":"L Eder","year":"2013","unstructured":"Eder L, Jayakar J, Shanmugarajah S et al (2013) The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone. Ann Rheum Dis 72:715\u2013720. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201497","journal-title":"Ann Rheum Dis"},{"key":"5556_CR51","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/art.40389","volume":"70","author":"A Szentpetery","year":"2018","unstructured":"Szentpetery A, Healy GM, Brady D et al (2018) Higher coronary plaque burden in psoriatic arthritis is independent of metabolic syndrome and associated with underlying disease severity. Arthritis Rheumatol 70:396\u2013407. https:\/\/doi.org\/10.1002\/art.40389","journal-title":"Arthritis Rheumatol"},{"key":"5556_CR52","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa0806576","volume":"359","author":"JM Miller","year":"2008","unstructured":"Miller JM, Rochitte CE, Dewey M et al (2008) Diagnostic performance of coronary angiography by 64-row CT. N Eng J Med 359:2324\u20132336. https:\/\/doi.org\/10.1056\/NEJMoa0806576","journal-title":"N Eng J Med"},{"key":"5556_CR53","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/joim.13311","volume":"290","author":"AB Tinggaard","year":"2021","unstructured":"Tinggaard AB, Hjuler KF, Andersen IT et al (2021) Prevalence and severity of coronary artery disease linked to prognosis in psoriasis and psoriatic arthritis patients: a multi-centre cohort study. J Intern Med 290:693\u2013703. https:\/\/doi.org\/10.1111\/joim.13311","journal-title":"J Intern Med"},{"key":"5556_CR54","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1136\/annrheumdis-2016-210390","volume":"76","author":"J Shen","year":"2017","unstructured":"Shen J, Wong KT, Cheng IT et al (2017) Increased prevalence of coronary plaque in patients with psoriatic arthritis without prior diagnosis of coronary artery disease. Ann Rheum Dis 76:1237\u20131244. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210390","journal-title":"Ann Rheum Dis"},{"key":"5556_CR55","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3899\/jrheum.180299","volume":"45","author":"M Haroon","year":"2018","unstructured":"Haroon M, Szentpetery A, Dodd JD et al (2018) Modifications of cardiovascular risk scores, but not standard risk scores, improve identification of asymptomatic coronary artery disease in psoriatic arthritis. J Rheumatol 45:1329\u20131330. https:\/\/doi.org\/10.3899\/jrheum.180299","journal-title":"J Rheumatol"},{"key":"5556_CR56","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00296-018-4039-8","volume":"38","author":"GL Erre","year":"2018","unstructured":"Erre GL, Buscetta G, Paliogiannis P et al (2018) Coronary flow reserve in systemic rheumatic diseases: a systematic review and meta-analysis. Rheumatol Int 38:1179\u20131190. https:\/\/doi.org\/10.1007\/s00296-018-4039-8","journal-title":"Rheumatol Int"},{"key":"5556_CR57","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/rheumatology\/kep082","volume":"48","author":"M Turiel","year":"2009","unstructured":"Turiel M, Atzeni F, Tomasoni L et al (2009) Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. Rheumatology (Oxford) 48:834\u2013839. https:\/\/doi.org\/10.1093\/rheumatology\/kep082","journal-title":"Rheumatology (Oxford)"},{"key":"5556_CR58","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.atherosclerosis.2007.11.013","volume":"198","author":"O Ciftci","year":"2008","unstructured":"Ciftci O, Yilmaz S, Topcu S et al (2008) Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis. Atherosclerosis 198:332\u2013337. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.11.013","journal-title":"Atherosclerosis"},{"key":"5556_CR59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.echo.2015.09.001","volume":"29","author":"K Kakuta","year":"2016","unstructured":"Kakuta K, Dohi K, Sato Y et al (2016) Chronic inflammatory disease is an independent risk factor for coronary flow velocity reserve impairment unrelated to the processes of coronary artery calcium deposition. J Am Soc Echocardiogr 29:173\u2013180. https:\/\/doi.org\/10.1016\/j.echo.2015.09.001","journal-title":"J Am Soc Echocardiogr"},{"key":"5556_CR60","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/acr.24108.Coronary","volume":"73","author":"KP Liao","year":"2021","unstructured":"Liao KP, Huang J, He Z et al (2021) Coronary microvascular dysfunction in rheumatoid arthritis compared to diabetes mellitus and association with all-cause mortality. Arthritis Care Res (Hoboken) 73:159\u2013165. https:\/\/doi.org\/10.1002\/acr.24108.Coronary","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5556_CR61","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/eurheartj\/ehp205","volume":"30","author":"A Recio-Mayoral","year":"2009","unstructured":"Recio-Mayoral A, Mason JC, Kaski JC et al (2009) Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J 30:1837\u20131843. https:\/\/doi.org\/10.1093\/eurheartj\/ehp205","journal-title":"Eur Heart J"},{"key":"5556_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12451","volume":"25","author":"P Anyfanti","year":"2018","unstructured":"Anyfanti P, Gkaliagkousi E, Triantafyllou A et al (2018) Dermal capillary rarefaction as a marker of microvascular damage in patients with rheumatoid arthritis: association with inflammation and disorders of the macrocirculation. Microcirculation 25:e12451. https:\/\/doi.org\/10.1111\/micc.12451","journal-title":"Microcirculation"},{"key":"5556_CR63","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/postgradmedj-2016-134068","volume":"93","author":"SZ Xu","year":"2017","unstructured":"Xu SZ, Wang P, Guan SY et al (2017) Decreased flow-mediated dilatation in patients with rheumatoid arthritis: a meta-analysis. Postgrad Med J 93:260\u2013265. https:\/\/doi.org\/10.1136\/postgradmedj-2016-134068","journal-title":"Postgrad Med J"},{"key":"5556_CR64","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.semarthrit.2011.08.003","volume":"41","author":"M Chatterjee Adhikari","year":"2012","unstructured":"Chatterjee Adhikari M, Guin A, Chakraborty S et al (2012) Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum 41:669\u2013675. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.08.003","journal-title":"Semin Arthritis Rheum"},{"key":"5556_CR65","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0002-9343(03)00133-5","volume":"114","author":"C Gonzalez-Juanatey","year":"2003","unstructured":"Gonzalez-Juanatey C, Testa A, Garcia-Castelo A et al (2003) HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 114:647\u2013652. https:\/\/doi.org\/10.1016\/S0002-9343(03)00133-5","journal-title":"Am J Med"},{"key":"5556_CR66","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1097\/HJH.0b013e3280b0157e","volume":"25","author":"E Arosio","year":"2007","unstructured":"Arosio E, De MS, Rigoni A et al (2007) Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis. J Hypertens 25:1273\u20131278. https:\/\/doi.org\/10.1097\/HJH.0b013e3280b0157e","journal-title":"J Hypertens"},{"key":"5556_CR67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/ard.2003.007740","volume":"63","author":"G Vaudo","year":"2004","unstructured":"Vaudo G, Marchesi S, Gerli R et al (2004) Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 63:31\u201335. https:\/\/doi.org\/10.1136\/ard.2003.007740","journal-title":"Ann Rheum Dis"},{"key":"5556_CR68","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jama.296.7.815","volume":"296","author":"MM Lederman","year":"2009","unstructured":"Lederman MM, Penn-Nicholson A, Cho M et al (2009) Biology of CCR5 and its role in HIV infection and treatment. JAMA 296:815\u2013826. https:\/\/doi.org\/10.1001\/jama.296.7.815","journal-title":"JAMA"},{"key":"5556_CR69","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cellsig.2004.04.007","volume":"16","author":"M Oppermann","year":"2004","unstructured":"Oppermann M (2004) Chemokine receptor CCR5: insights into structure, function, and regulation. Cell Signal 16:1201\u20131210. https:\/\/doi.org\/10.1016\/j.cellsig.2004.04.007","journal-title":"Cell Signal"},{"key":"5556_CR70","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1074\/jbc.275.8.5466","volume":"275","author":"AD Schecter","year":"2000","unstructured":"Schecter AD, Calderon TM, Berman AB et al (2000) Human vascular smooth muscle cells possess functional CCR5. J Biol Chem 275:5466\u20135471. https:\/\/doi.org\/10.1074\/jbc.275.8.5466","journal-title":"J Biol Chem"},{"key":"5556_CR71","doi-asserted-by":"publisher","first-page":"R133","DOI":"10.1186\/ar3444","volume":"13","author":"L Rodr\u00edguez-Rodr\u00edguez","year":"2011","unstructured":"Rodr\u00edguez-Rodr\u00edguez L, Gonz\u00e1lez-Juanatey C, Garc\u00eda-Berm\u00fadez M et al (2011) CCR5\u039432 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. Arthritis Res Ther 13:R133. https:\/\/doi.org\/10.1186\/ar3444","journal-title":"Arthritis Res Ther"},{"key":"5556_CR72","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3899\/jrheum.141295","volume":"42","author":"K Becetti","year":"2015","unstructured":"Becetti K, Oeser A, Ormseth MJ et al (2015) Urinary albumin excretion is increased in patients with rheumatoid arthritis and associated with arterial stiffness. J Rheumatol 42:593\u2013598. https:\/\/doi.org\/10.3899\/jrheum.141295","journal-title":"J Rheumatol"},{"key":"5556_CR73","doi-asserted-by":"publisher","first-page":"427","DOI":"10.11152\/mu-2001","volume":"21","author":"CV Petra","year":"2019","unstructured":"Petra CV, Albu A, Pamfil C et al (2019) The relationship between epicardial adipose tissue and arterial stiffness in patients with rheumatoid arthritis. Med Ultrason 21:427\u2013434. https:\/\/doi.org\/10.11152\/mu-2001","journal-title":"Med Ultrason"},{"key":"5556_CR74","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-3-030-11488-6_9","volume":"1127","author":"G Berg","year":"2019","unstructured":"Berg G, Miksztowicz V, Morales C et al (2019) Epicardial adipose tissue in cardiovascular disease. Adv Exp Med Biol 1127:131\u2013143. https:\/\/doi.org\/10.1007\/978-3-030-11488-6_9","journal-title":"Adv Exp Med Biol"},{"key":"5556_CR75","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1113\/JP273049","volume":"595","author":"AS Antonopoulos","year":"2017","unstructured":"Antonopoulos AS, Antoniades C (2017) The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles. J Physiol 595:3907\u20133917. https:\/\/doi.org\/10.1113\/JP273049","journal-title":"J Physiol"},{"key":"5556_CR76","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ijcard.2018.09.089","volume":"278","author":"AM Ansaldo","year":"2019","unstructured":"Ansaldo AM, Montecucco F, Sahebkar A et al (2019) Epicardial adipose tissue and cardiovascular diseases. Int J Cardiol 278:254\u2013260. https:\/\/doi.org\/10.1016\/j.ijcard.2018.09.089","journal-title":"Int J Cardiol"},{"key":"5556_CR77","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","volume":"19","author":"G Iacobellis","year":"2022","unstructured":"Iacobellis G (2022) Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol 19:593\u2013606. https:\/\/doi.org\/10.1038\/s41569-022-00679-9","journal-title":"Nat Rev Cardiol"},{"key":"5556_CR78","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s12265-019-09892-3","volume":"12","author":"L Mokotedi","year":"2019","unstructured":"Mokotedi L, Gunter S, Robinson C et al (2019) Early wave reflection and pulse wave velocity are associated with diastolic dysfunction in rheumatoid arthritis. J Cardiovasc Transl Res 12:580\u2013590. https:\/\/doi.org\/10.1007\/s12265-019-09892-3","journal-title":"J Cardiovasc Transl Res"},{"key":"5556_CR79","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1007\/s10067-015-3163-z","volume":"35","author":"A Ilter","year":"2016","unstructured":"Ilter A, Kiris A, Karkucak M et al (2016) Arterial stiffness is associated with left ventricular dysfunction in patients with rheumatoid arthritis. Clin Rheumatol 35:2663\u20132668. https:\/\/doi.org\/10.1007\/s10067-015-3163-z","journal-title":"Clin Rheumatol"},{"key":"5556_CR80","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.atherosclerosis.2018.03.004","volume":"271","author":"A Lo Gullo","year":"2018","unstructured":"Lo Gullo A, Rodr\u00edguez-Carrio J, Aragona CO et al (2018) Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: association with vitamin D and inflammation. Atherosclerosis 271:214\u2013222. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.03.004","journal-title":"Atherosclerosis"},{"key":"5556_CR81","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.semarthrit.2010.06.006","volume":"40","author":"AM van Sijl","year":"2011","unstructured":"van Sijl AM, Peters MJ, Knol DK et al (2011) Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum 40:389\u2013397. https:\/\/doi.org\/10.1016\/j.semarthrit.2010.06.006","journal-title":"Semin Arthritis Rheum"},{"key":"5556_CR82","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10067-015-3130-8","volume":"35","author":"P Wang","year":"2016","unstructured":"Wang P, Guan S, Xu S et al (2016) Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis. Clin Rheumatol 35:315\u2013323. https:\/\/doi.org\/10.1007\/s10067-015-3130-8","journal-title":"Clin Rheumatol"},{"key":"5556_CR83","first-page":"1219","volume":"32","author":"MA Gonzalez-Gay","year":"2005","unstructured":"Gonzalez-Gay MA, Gonzalez-Juanatey C, Pi\u00f1eiro A et al (2005) High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 32:1219\u20131223","journal-title":"J Rheumatol"},{"key":"5556_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2323","volume":"9","author":"S Hannawi","year":"2007","unstructured":"Hannawi S, Haluska B, Marwick TH et al (2007) Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther 9:1\u20139. https:\/\/doi.org\/10.1186\/ar2323","journal-title":"Arthritis Res Ther"},{"key":"5556_CR85","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00296-006-0176-6","volume":"27","author":"A Pahor","year":"2006","unstructured":"Pahor A, Hojs R, Gorenjak M et al (2006) Accelerated atherosclerosis in pre-menopausal female patients with rheumatoid arthritis. Rheumatol Int 27:119\u2013123. https:\/\/doi.org\/10.1007\/s00296-006-0176-6","journal-title":"Rheumatol Int"},{"key":"5556_CR86","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3132\/dvdr.2007.031","volume":"4","author":"G la Montagna","year":"2007","unstructured":"la Montagna G, Cacciapuoti F, Buono R et al (2007) Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis. Diabetes Vasc Dis Res 4:130\u2013135. https:\/\/doi.org\/10.3132\/dvdr.2007.031","journal-title":"Diabetes Vasc Dis Res"},{"key":"5556_CR87","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1196\/annals.1381.004","volume":"1107","author":"E Pingiotti","year":"2007","unstructured":"Pingiotti E, Cipriani P, Marrelli A et al (2007) Surface expression of fractalkine receptor (CX3CR1) on CD4+\/CD28\u2212 T cells in RA patients and correlation with atherosclerotic damage. Ann N Y Acad Sci 1107:32\u201341. https:\/\/doi.org\/10.1196\/annals.1381.004","journal-title":"Ann N Y Acad Sci"},{"key":"5556_CR88","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1161\/CIRCRESAHA.111.261933","volume":"110","author":"IE Dumitriu","year":"2012","unstructured":"Dumitriu IE, Baruah P, Finlayson CJ et al (2012) High levels of costimulatory receptors OX40 and 4\u20131BB characterize CD4+CD28 null T cells in patients with acute coronary syndrome. Circ Res 110:857\u2013869. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.261933","journal-title":"Circ Res"},{"key":"5556_CR89","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1161\/01.cir.101.25.2883","volume":"101","author":"G Liuzzo","year":"2000","unstructured":"Liuzzo G, Goronzy JJ, Yang H et al (2000) Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 101:2883\u20132888. https:\/\/doi.org\/10.1161\/01.cir.101.25.2883","journal-title":"Circulation"},{"key":"5556_CR90","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/01.ATV.0000095360.62479.1F","volume":"24","author":"H Umehara","year":"2004","unstructured":"Umehara H, Bloom ET, Okazaki T et al (2004) Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 24:34\u201340. https:\/\/doi.org\/10.1161\/01.ATV.0000095360.62479.1F","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5556_CR91","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jaad.2013.06.019","volume":"69","author":"H J\u00f3kai","year":"2013","unstructured":"J\u00f3kai H, Szakonyi J, Kont\u00e1r O et al (2013) Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: results of a pilot study. J Am Acad Dermatol 69:523\u2013529. https:\/\/doi.org\/10.1016\/j.jaad.2013.06.019","journal-title":"J Am Acad Dermatol"},{"key":"5556_CR92","doi-asserted-by":"publisher","first-page":"711","DOI":"10.20996\/1819-6446-2018-14-5-711-715","volume":"14","author":"EI Markelova","year":"2018","unstructured":"Markelova EI, Novikova DS, Korotaeva T et al (2018) Dynamics of carotid intima-media thickness, parameters of arterial stiffness and ambulatory blood pressure monitoring during therapy with inhibitor of tumor necrosis factor-alpha in patients with early psoriatic arthritis. Ration Pharmacother Cardiol 14:711\u2013715. https:\/\/doi.org\/10.20996\/1819-6446-2018-14-5-711-715","journal-title":"Ration Pharmacother Cardiol"},{"key":"5556_CR93","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/art.39098","volume":"67","author":"DH Solomon","year":"2015","unstructured":"Solomon DH, Reed GW, Kremer JM et al (2015) Disease activity in rheumatoid arthritis and the risk of cardiovascular events. Arthritis Rheumatol 67:1449\u20131455. https:\/\/doi.org\/10.1002\/art.39098","journal-title":"Arthritis Rheumatol"},{"key":"5556_CR94","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/art.11078","volume":"48","author":"I del Rinc\u00f3n","year":"2003","unstructured":"del Rinc\u00f3n I, Williams K, Stern MP et al (2003) Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 48:1833\u20131840. https:\/\/doi.org\/10.1002\/art.11078","journal-title":"Arthritis Rheum"},{"key":"5556_CR95","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3899\/jrheum.090670","volume":"37","author":"H Kobayashi","year":"2010","unstructured":"Kobayashi H, Giles JT, Polak JF et al (2010) Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specific. J Rheumatol 37:730\u2013739. https:\/\/doi.org\/10.3899\/jrheum.090670","journal-title":"J Rheumatol"},{"key":"5556_CR96","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/art.30265","volume":"63","author":"MR Evans","year":"2011","unstructured":"Evans MR, Escalante A, Battafarano DF et al (2011) Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis Rheum 63:1211\u20131220. https:\/\/doi.org\/10.1002\/art.30265","journal-title":"Arthritis Rheum"},{"key":"5556_CR97","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11926-012-0271-5","volume":"14","author":"C Charles-Schoeman","year":"2012","unstructured":"Charles-Schoeman C (2012) Cardiovascular disease and rheumatoid arthritis: an update. Curr Rheumatol Rep 14:455\u2013462. https:\/\/doi.org\/10.1007\/s11926-012-0271-5","journal-title":"Curr Rheumatol Rep"},{"key":"5556_CR98","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/1744666X.2021.1899809","volume":"17","author":"GA Karpouzas","year":"2021","unstructured":"Karpouzas GA, Bui VL, Ronda N et al (2021) Biologics and atherosclerotic cardiovascular risk in rheumatoid arthritis: a review of evidence and mechanistic insights. Expert Rev Clin Immunol 17:355\u2013374. https:\/\/doi.org\/10.1080\/1744666X.2021.1899809","journal-title":"Expert Rev Clin Immunol"},{"key":"5556_CR99","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12246","volume":"12","author":"K Mal","year":"2020","unstructured":"Mal K, Kumar R, Mansoor F et al (2020) Risk of major adverse cardiovascular events in patients with rheumatoid arthritis. Cureus 12:e12246. https:\/\/doi.org\/10.7759\/cureus.12246","journal-title":"Cureus"},{"key":"5556_CR100","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3899\/jrheum.190729","volume":"47","author":"N Palmou-Fontana","year":"2020","unstructured":"Palmou-Fontana N, Mart\u00ednez-Lopez D, Corrales A et al (2020) Disease activity influences cardiovascular risk reclassification based on carotid ultrasound in patients with psoriatic arthritis. J Rheumatol 47:1344\u20131353. https:\/\/doi.org\/10.3899\/jrheum.190729","journal-title":"J Rheumatol"},{"key":"5556_CR101","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1136\/annrheumdis","volume":"73","author":"L Eder","year":"2013","unstructured":"Eder L, Chandran V, Gladman DD (2013) The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Ann Rheum Dis 73:1990\u20131996. https:\/\/doi.org\/10.1136\/annrheumdis","journal-title":"Ann Rheum Dis"},{"key":"5556_CR102","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00296-016-3617-x","volume":"37","author":"R Ib\u00e1\u00f1ez-Bosch","year":"2017","unstructured":"Ib\u00e1\u00f1ez-Bosch R, Restrepo-Velez J, Medina-Malone M et al (2017) High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound. Rheumatol Int 37:107\u2013112. https:\/\/doi.org\/10.1007\/s00296-016-3617-x","journal-title":"Rheumatol Int"},{"key":"5556_CR103","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jbspin.2014.02.005","volume":"81","author":"R Ramonda","year":"2014","unstructured":"Ramonda R, Puato M, Punzi L et al (2014) Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: a two-year prospective observational study. Jt Bone Spine 81:421\u2013425. https:\/\/doi.org\/10.1016\/j.jbspin.2014.02.005","journal-title":"Jt Bone Spine"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05556-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05556-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05556-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T02:02:39Z","timestamp":1724464959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05556-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,24]]},"references-count":103,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["5556"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05556-x","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,24]]},"assertion":[{"value":"6 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors has any conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}